Active — Not RecruitingNot Applicable

Educational Intervention for Patients Undergoing Surgery for Lung Cancer

Greece160 participantsStarted 2021-01-01

Plain-language summary

The goal of this interventional study is to learn about the effect of a structured educational intervention in patients undergoing surgery for lung cancer. The study will examine whether this intervention can improve patients' acceptance of the disease, quality of life, pain levels, and postoperative clinical and biometric outcomes. The main question it aims to answer is: Does a structured educational intervention improve disease acceptance, quality of life, pain levels, and postoperative clinical and biometric outcomes in patients undergoing surgery for lung cancer? Participants are assigned to two groups. Participants in the intervention group receive a structured educational intervention in addition to usual care, while participants in the control group receive usual care only. Data are collected through questionnaires and clinical and biometric measurements after surgery, with follow-up assessments over a 5-year period.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with lung cancer. * Patients admitted to the referral hospital and undergoing surgical treatment for lung cancer. * Age older than 18 years. * Signed written informed consent. * Ability to speak, understand, and read the Greek language. * Undisturbed level of consciousness allowing cooperation with the researcher and the healthcare team. * Ability to participate in a personal interview and complete the study questionnaires. * Availability of a supportive psychosocial network/caregiver, where required for participation in the educational intervention. Exclusion Criteria: * Inability to provide written informed consent. * Inability to speak, understand, or read the Greek language. * Impaired level of consciousness that prevents cooperation. * Presence of a chronic condition affecting behavior or ability to cooperate with the study procedures. * Lack of a supportive psychosocial network. * Inability to cooperate with the medical and nursing staff. * Inability to participate in the interview process or complete the required study assessments.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Disease Acceptance

Timeframe: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery

Change in Global Health Status/Quality of Life Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)

Timeframe: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery

Change in Functional Status Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30

Timeframe: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.

Change in Cancer-Related Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30

Timeframe: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.

Change in Lung Cancer-Specific Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13

Timeframe: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.

Trial details

NCT IDNCT07614204

SponsorNational and Kapodistrian University of Athens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-01-01

View on ClinicalTrials.gov More Lung Cancer trials